Distribution of CCK binding sites in the human hippocampal formation and their alteration in schizophrenia: A post-mortem autoradiographic study

Psychological Medicine

Volumn 22, Issue 1, 1992, Pages 37-43

  Kerwin, R ^a   Robinson, P ^a   Stephenson, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HOMOGENATE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBICULUM;

ADULT; AGED; AUTORADIOGRAPHY; BRAIN MAPPING; CHOLECYSTOKININ; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MIDDLE AGE; RECEPTORS, CHOLECYSTOKININ; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, NON-U.S. GOV'T; TEMPORAL LOBE;

EID: 0026545280     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700032700     Document Type: Article

References (25)

1. Bogerts, B., Meertz, E. & Schonfeldt-Bausch, R. (1985). Basal ganglia and limbic system pathology in schizophrenia. Archives of General Psychiatry 42, 784-791.
2. Brown, R., Colter, N., Corsellis, J. A. W., Crow, T.J., Frith, C. D., Jagoe, R., Johnstone, E. C. & Marsh, L. (1986). Post-mortem evidence of structural brain changes in schizophrenia. Archives of General Psychiatry 43, 36-42.
3. Carruthers, B., Dawbarn, D., de Quidt, M., Ellison, P., Hunter, J. & Reynolds, G. P. (1984). Changes in neuropeptide content of amygdala in schizophrenia. British Journal of Pharmacology 81, 139P.
4. Chun, J. J. M., Makamura, M. J. & Shatz, C. J. (1987). Transient cells of the developing mammalian telencephalon are peptide immuno reactive neurones. Nature 325, 617 620.
5. Crow, T. J., Ferrier, I. N., Johnstone, E. C., Owens, D. G. C., Roberts, G. W., Lee, Y. C., Bloom, S. R. & Polak, J. M. (1982). Neuroendocrine aspects of schizophrenia. In Neuropeptides: Basic and Clinical Aspects (ed. G. Fink and L. J. Whalley), pp. 222 239. Churchill-Livingstone: Edinburgh.
6. Dietl, M. M., Probst, A. & Palacios, J. M. (1987). On the distribution of cholecystokinin receptor binding sites in the human brain: an autoradiographic study. Synapse 1, 169-183.
7. Falkai, P. & Bogerts, B. (1986). Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatric and Neurological Science 23, 154-161.
8. Falkai, P. & Bogerts, B. (1989). Morphometric evidence for developmental disturbances in the brains of some schizophrenics. Schizophrenia Research 2, 99.
9. Farmery, S. M., Owen, F., Poulter, M. & Crow, T. J. (1985). Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients. Life Sciences 36, 473 477.
10. Ferrier, I. N., Crow, T. J., Farmery, S. M., Owens, D. G. C., Roberts, G. W., Adrian, T. E. & Bloom, S. R. (1985). Reduced CCK in the limbic lobe in schizophrenia: a marker for the defect state in schizophrenia. Annals of the New York Academy of Sciences 448, 495-500.
11. Garcha, G. S., McHugh, P. R., Moran, T. H., Robinson, P. H. & Stephenson, J. D. (1987). Development of cholecystokinin receptors and suppression of ingestion and gastric emptying in the rat. Journal of Physiology 387, 93P.
12. Handelmann, G. E., Meyer, D. G., Beinfield, M. C. & Oertel, W. H. (1981). CCK containing terminals in the hippocampus are derived from intrinsic neurons. An immunohistological and radio immunological study. Brain Research 224, 181-185.
13. Herkenham, M. & McLean, S. (1986). Mismatches between receptor and transmitter localisations in the brain. In Quantitative Autoradiography (ed. C. A. Boast, E. W. Snowhill and C. Altar), pp. 137-171. Alan R. Liss: New York.
14. Innis, R. B. & Snyder, S. H. (1980). Distinct cholecystokinin receptors in brain and pancreas. Proclamations of the National Academy of Sciences 77, 6917-6921.
15. Jakob, H. & Beckmann, H. (1986). Prenatal development disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission 65, 303 326.
16. Kohler, C. & Chan-Palay, V. C. (1982). The distribution of cholecystokinin-like immunoreactive neurons and nerve terminals in the retrohippocampal region in the rat and guinea-pig. Journal of Comparative Neurology 210, 136 146.
17. Kohler, C. & Chan-Palay, V. C. (1988). Cholecystokinin octapeptide (CCK-8) receptors in the hippocampal region: a comparative in vitro autoradiographic study in the rat, monkey and the post-mortem human brain. Neuroscience Letters 90, 51 56.
18. Kovelman, J. A. & Scheibel, A. B. (1984). A neurohistological correlate of schizophrenia. Biological Psychiatry 191, 1601-1621.
19. Marley, P. D., Rehfeld, J. F. & Emson, P. C. (1984). Distribution and chromatographic characterisation of gastric and cholecystokinin in the rat central nervous system. Journal of Neurochemistry 42, 1523-1535.
20. Montgomery, S. & Green, M. C. D. (1988). The use of cholecystokinin in schizophrenia: a review. Psychological Medicine 18, 593 603.
21. Perry, R. H., Dockray, G. J., Dimaline, R., Perry, E. K., Blessed, G. & Tomlinson, D. E. (1981). Neuropeptides in Alzheimer's Disease, depression and schizophrenia. Journal of Neurological Science 51, 465-472.
22. Roberts, G. W., Ferrier, I. N., Lee, Y., Crow, T. J., Johnstone, E. C., Owens, D. G. C., Barceresa-Hamilton, A. J., MacGregor, G., O'shaughnessy, D., Polack, J. M. & Bloom, S. R. (1983). Peptides: the timbic lobe and schizophrenia. Brain Research 288, 199-211.
23. Roberts, G. W. & Bruton, C. J. (1990). Notes from the graveyard: neuropathology and schizophrenia. Neuropathology and Applied Neurobiology 16, 3-16.
24. Somogyi, P., Hodgson, A. J., Smith, A. D., Nunzi, G., Gorio, A. & Wu, J. Y. (1984). Different populations of GABAergic neurons in the visual cortex and hippocampus contain somatostatin or cholecystokinin immunoreactive material. Journal of Neuroscience 4, 2590-2603.
25. Van-Dijk, A., Richards, J. G., Trzeciak, A., Gillessen, D. & Mohler, H. (1984). Cholecystokinin receptors: biochemical demonstration and autoradiographical localisation in rat brain and pancreas using 3H cholecystokinin as radioligand. Journal of Neuroscience 4, 1021-1033.